Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 40, 2023 - Issue 4
Submit an article Journal homepage
193
Views
0
CrossRef citations to date
0
Altmetric
Articles

Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with opsoclonus–myoclonus syndrome associated with neuroblastoma

Kazuhiro Noguchia Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
,
Yasuhiro Ikawaa Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7204-1766
ORCID Icon,
Mika Takenakaa Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
,
Yuta Sakaia Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
,
Toshihiro Fujikia Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
,
Rie Kurodaa Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
,
Hiroko Ikedab Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan
,
Satoko Nakadab Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan
,
Kozo Nomurac Department of Pediatric Surgery, Kanazawa University Hospital, Kanazawa, Japan
,
Seisho Sakaic Department of Pediatric Surgery, Kanazawa University Hospital, Kanazawa, Japan
,
Masaki Fukudad Department of Pediatrics, Ishikawa Prefectural Central Hospital, Kanazawa, Japan
,
Raita Arakid Department of Pediatrics, Ishikawa Prefectural Central Hospital, Kanazawa, Japan
,
Yukitoshi Takahashie National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan
&
Taizo Wadaa Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan
 show all
Pages 363-370 | Received 20 Dec 2021, Accepted 29 Jul 2022, Published online: 20 Sep 2022

References

  • Wells EM, Dalmau J. Paraneoplastic neurologic disorders in children. Curr Neurol Neurosci Rep. 2011;11(2):187–194. doi:10.1007/s11910-010-0169-4. PMID: 21161703.
  • Meena JP, Seth R, Chakrabarty B, Gulati S, Agrawala S, Naranje P. Neuroblastoma presenting as opsoclonus-myoclonus: a series of six cases and review of literature. J Pediatr Neurosci. 2016;11(4):373–377. doi:10.4103/1817-1745.199462. PMID: 28217170.
  • Pranzatelli MR, Slev PR, Tate ED, Travelstead AL, Colliver JA, Joseph SA. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus. Pediatr Neurol. 2011;45(1):27–33. doi:10.1016/j.pediatrneurol.2011.02.012. PMID: 21723456.
  • Berridge G, Menassa DA, Moloney T, et al. Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome. Neurology. 2018;91(8):e714–e723. doi:10.1212/WNL.0000000000006035. PMID: 30045961.
  • de Alarcon PA, Matthay KK, London WB, et al. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health. 2018;2(1):2:25–34. doi:10.1016/S2352-4642(17)30130-X. PMID: 29376112.
  • Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol. 1996;19(1):1–47. doi:10.1097/00002826-199619010-00001. PMID: 8867515.
  • de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW. Flow cytometric characterization of cerebrospinal fluid cells. Cytometry B Clin Cytom. 2011;80(5):271–281. doi:10.1002/cyto.b.20603. PMID: 21567940.
  • Ertle F, Behnisch W, Al Mulla NA, et al. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses. Pediatr Blood Cancer. 2008;50(3):683–687. doi:10.1002/pbc.21107. PMID: 17226843.
  • Mitchell WG, Wooten AA, O’Neil SH, Rodriguez JG, Cruz RE, Wittern R. Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS). J Child Neurol. 2015;30(8):976–982. doi:10.1177/0883073814549581. PMID: 25342308.
  • Kitaura K, Yamashita H, Ayabe H, Shini T, Matsutani T, Suzuki R. Different somatic hypermutation levels among antibody subclasses disclosed by a new next-generation sequencing-based antibody repertoire analysis. Front Immunol. 2017;8:389. doi:10.3389/fimmu.2017.00389. PMID: 28515723.
  • Gambini C, Conte M, Bernini G, et al. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases. Virchows Arch. 2003;442(6):555–562. doi:10.1007/s00428-002-0747-1. PMID: 12709798.
  • Pranzatelli MR, Travelstead AL, Tate ED, et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology. 2004;62(9):1526–1532. doi:10.1212/wnl.62.9.1526. PMID: 15136676.
  • Sato Y, Shimoda M, Sota Y, et al. Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody. Cancer Med. 2021;10(4):1418–1430. doi:10.1002/cam4.3742. PMID: 33506656.
  • Katoh H, Komura D, Konishi H, et al. Immunogenetic profiling for gastric cancers identifies sulfated glycosaminoglycans as major and functional B cell antigens in human malignancies. Cell Rep. 2017;20(5):1073–1087. doi:10.1016/j.celrep.2017.07.016. PMID: 28768193.
  • Pranzatelli MR, Tate ED, Swan JA, et al. B cell depletion therapy for new-onset opsoclonus-myoclonus. Mov Disord. 2010;25(2):238–242. doi:10.1002/mds.22941. PMID: 20063398.
  • Pranzatelli MR, Tate ED, Travelstead AL, et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol. 2006;28(9):585–593. doi:10.1097/01.mph.0000212991.64435.f0. PMID: 17006265.
  • Patel A, Fischer C, Lin YC, et al. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience. Pediatr Blood Cancer. 2020;67(8):e28319. doi:10.1002/pbc.28319. PMID: 32543116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.